1:18 PM
 | 
Feb 11, 2019
 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Mesothelioma

Cell and mouse studies suggest GHRH receptor antagonists could help treat malignant pleural mesothelioma (MPM). In two human-derived MPM cell lines and patient-derived MPM cells, two previously identified GHRH receptor...

Read the full 138 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >